Latest stories on CTSO
CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights
PR Newswire50 · neutralgeneral
WBB Securities initiates CytoSorbents stock with Speculative Buy
Investing.com Analyst Ratings64 · neutralanalyst
CytoSorbents initiated with a Speculative Buy at WBB Securities
The Fly64 · neutralanalyst
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care
PR Newswire63 · neutralproduct/pr
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
CytoSorbents regains Nasdaq minimum bid price requirement compliance
Seeking Alpha63 · neutralgeneral
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire59 · neutralgeneral
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire55 · neutralgeneral
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
CytoSorbents trading halted, news pending
The Fly50 · neutralgeneral
CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Business Insider56 · neutralgeneral
CytoSorbents to execute 1:20 reverse stock split
Seeking Alpha25 · bearishgeneral
CytoSorbents announces 1-for-20 reverse stock split
The Fly25 · bearishgeneral
CytoSorbents Announces Reverse Stock Split
PR Newswire25 · bearishgeneral
CytoSorbents announces real-world data using CytoSorb
The Fly59 · neutralproduct/pr
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Cytosorbents Corporation 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Cytosorbents Advances Toward Operating Cash Flow Breakeven
TipRanks56 · neutralgeneral
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
Cytosorbents plans to add 3 to 5 Germany sales reps through early 2027 while targeting second-half 2026 operating cash flow breakeven
Seeking Alpha67 · bullishproduct/pr
Cytosorbents Corporation (CTSO) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Cytosorbents Non-GAAP EPS of -$0.05, revenue of $9.63M beats by $0.28M
Seeking Alpha56 · neutralearnings
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
PR Newswire50 · neutralgeneral